They 'expanded' it to Europe almost 12 months ago.
Can't see anyone being dosed prior to the first shipment of IV formulation - due by June '23.
I was actually surprised they released the cardio findings. Could mean they're already shopping around the IP and were required to inform shareholders of the data (level playing field). The board could fall arse-backwards into a transaction here. I'm going to be very annoyed if DCB doesn't get the chance to flesh out our opportunity.
General Comments / Chat, page-7118
-
- There are more pages in this discussion • 4,196 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.56 | $1.51 | $95.69K | 62.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3015 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 4018 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |